Reports on expired vaccines being used in India false, misleading: Govt

The Union health ministry on Monday dismissed media reports alleging that expired vaccines are being administered in the country under its COVID-19 vaccination programme as "false and misleading".

coronavirus, covid-19, vaccine, vaccination
A medical professional in Delhi administers a Covid-19 vaccine dose to a worker employed in the construction of the Central Vista on November 27, 2021. (PTI Photo/ Shahbaz Khan)
Press Trust of India New Delhi
1 min read Last Updated : Jan 03 2022 | 5:07 PM IST

The Union health ministry on Monday dismissed media reports alleging that expired vaccines are being administered in the country under its COVID-19 vaccination programme as "false and misleading".

"There have been some media reports alleging that expired vaccines are being administered in India under its national COVID-19 vaccination programme. This is false and misleading and based on incomplete information," the ministry said in a statement.

On October 25, 2021, in response to Bharat Biotech International Limited's letter, the Central Drugs Standard Control Organisation (CDSCO) approved the extension of the shelf life of Covaxin (Whole Virion, Inactivated Coronavirus Vaccine) from nine months to 12 months, the ministry said.

Similarly, the shelf life of Covishield was extended by the drug regulator from six months to 9 months on February 22, 2021.

The shelf life of vaccines is extended by the CDSCO on the basis of a comprehensive analysis and examination of the stability study data furnished by the vaccine manufacturers, the ministry said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineCoronavirus Tests

First Published: Jan 03 2022 | 5:07 PM IST

Next Story